Other equities analysts have also issued reports about the company. HC Wainwright set a $4.00 price target on Aquabounty Technologies and gave the company a buy rating in a research note on Thursday, July 11th. National Securities reissued a buy rating and set a $5.00 price target on shares of Aquabounty Technologies in a research note on Monday, June 10th.
Shares of Aquabounty Technologies stock opened at $3.24 on Friday. The company’s 50 day moving average price is $3.24. Aquabounty Technologies has a 12 month low of $1.51 and a 12 month high of $5.45. The company has a debt-to-equity ratio of 0.16, a current ratio of 7.24 and a quick ratio of 7.10.
About Aquabounty Technologies
AquaBounty Technologies, Inc, a biotechnology company, develops and markets products to enhance productivity in aquaculture. It offers AquAdvantage Salmon, a genetically modified Atlantic salmon for human consumption. The company was formerly known as Aqua Bounty Farms, Inc and changed its name to AquaBounty Technologies, Inc in June 2004.
Featured Story: What is the G-20?
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for Aquabounty Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aquabounty Technologies and related companies with MarketBeat.com's FREE daily email newsletter.